Herpes zoster (Shingles) and postherpetic neuralgia

Mayo Clinic Proceedings

Volumn 84, Issue 3, 2009, Pages 274-280

  Sampathkumar, Priya ^a   Drage, Lisa A ^a   Martin, David P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CAPSAICIN; CARBAMAZEPINE; CHICKENPOX VACCINE; CORTICOSTEROID DERIVATIVE; DULOXETINE; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PREDNISONE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR; VALPROIC ACID; VARICELLA ZOSTER VACCINE; VENLAFAXINE;

ALLODYNIA; ANALGESIA; BACTERIAL STRAIN; BEDTIME DOSAGE; CLINICAL FEATURE; COMORBIDITY; COST BENEFIT ANALYSIS; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; MORBIDITY; MORTALITY; PAIN; POSTHERPETIC NEURALGIA; REVIEW; STAINING; UNSPECIFIED SIDE EFFECT; VIRUS CULTURE;

EID: 62749111502     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.3.274     Document Type: Review

References (23)

1. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005;352(22):2266-2267.
2. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2008;57(28): 779]. MMWR Recomm Rep. 2008;57(RR-5):1-30.
3. Yawn BP, Saddier P, Wollan P, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction [published correction appears in Mayo Clin Proc. 2008;83(2):255]. Mayo Clin Proc. 2007 Nov;82(11):1341-1349.
4. Gnann JW Jr. Vaccination to prevent herpes zoster in older adults. J Pain. 2008;9(1)(suppl 1):S31-S36.
5. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2)(suppl): S3-S12.
6. Atkinson K, Meyers JD, Storb R, Prentice RL, Thomas ED. Varicellazoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation. 1980;29(1):47-50.
7. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis. 1985;152(6): 1172-1181.
8. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus [published correction appears in N Engl J Med. 2000;342(14):1063]. N Engl J Med. 2000;342(9):635-645.
9. Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(suppl 1):S91-S98.
10. Espy MJ, Teo R, Ross TK, et al. Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol. 2000;38(9):3187-3189.
11. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA. 2004; 292(6):704-708.
12. Shafran SD, Tyring SK, Ashton R, et al. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol. 2004;29(4):248-253.
13. Shen MC, Lin HH, Lee SS, Chen YS, Chiang PC, Liu YC. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect. 2004;37(2):75-81.
14. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994; 330(13):896-900.
15. Whitley RJ, Weiss H, Gnann JW Jr, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med. 1996;125(5):376-383.
16. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain. 1996;65(1):39-44.
17. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 1989;21(2, pt 1):265-270.
18. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15(3):510-526.
19. Wu CL, Raja SN. An update on the treatment of postherpetic neuralgia. J Pain. 2008;9(1, suppl 1):S19-S30.
20. Sabatowski R, Gálvez R, Cherry DA, et al; 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109(1-2):26-35.
21. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280(21):1837-1842.
22. Oxman MN, Levin MJ, Johnson GR, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271-2284.
23. CDC vaccine price list Web site. http://www.cdc.gov/vaccines/programs/ vfc/cdc-vac-price-list.htm#adult. Accessed February 4, 2009.